The Food and Drug Administration approved a new type of drug that combines the widely used breast cancer medicine Herceptin with a powerful toxin to more effectively kill cancer cells while potentially reducing side effects. The drug, which will be called Kadcyla but...
If you are new to the IBC Network, you might not be familiar with Lori Grennan, a young physician and mother of two, diagnosed with Inflammatory Breast Cancer a few years ago. If you have been with us for awhile, you will know her name and understand what an...